127 related articles for article (PubMed ID: 18401217)
1. Cardiomyopathy associated with ephedra-containing nutritional supplements.
Singh A; Rajeev AG; Dohrmann ML
Congest Heart Fail; 2008; 14(2):89-90. PubMed ID: 18401217
[No Abstract] [Full Text] [Related]
2. [Ephedrine and ephedra in weight loss products and other preparations].
van der Hooft CS; Stricker BH
Ned Tijdschr Geneeskd; 2002 Jul; 146(28):1335-6. PubMed ID: 12148223
[TBL] [Abstract][Full Text] [Related]
3. JAMA patient page. Ephedra and ephedrine.
Torpy JM; Lynm C; Glass RM
JAMA; 2003 Mar; 289(12):1590. PubMed ID: 12672776
[No Abstract] [Full Text] [Related]
4. Multi-ingredient, caffeine-containing dietary supplements: history, safety, and efficacy.
Gurley BJ; Steelman SC; Thomas SL
Clin Ther; 2015 Feb; 37(2):275-301. PubMed ID: 25262198
[TBL] [Abstract][Full Text] [Related]
5. Ephedra: once a boon, now a bane.
Scheindlin S
Mol Interv; 2003 Oct; 3(7):358-60. PubMed ID: 14993455
[No Abstract] [Full Text] [Related]
6. Ephedra-associated cardiomyopathy.
Naik SD; Freudenberger RS
Ann Pharmacother; 2004 Mar; 38(3):400-3. PubMed ID: 14742827
[TBL] [Abstract][Full Text] [Related]
7. Final rule declaring dietary supplements containing ephedrine alkaloids adulterated because they present an unreasonable risk. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2004 Feb; 69(28):6787-854. PubMed ID: 14968803
[TBL] [Abstract][Full Text] [Related]
8. Banning ephedra: good call, poor vision.
Gordon JS
Altern Ther Health Med; 2004; 10(6):18-9. PubMed ID: 15624346
[No Abstract] [Full Text] [Related]
9. Ephedra in perspective--a current review.
Abourashed EA; El-Alfy AT; Khan IA; Walker L
Phytother Res; 2003 Aug; 17(7):703-12. PubMed ID: 12916063
[TBL] [Abstract][Full Text] [Related]
10. The federal ban on ephedrine dietary supplements:an important event for pain practitioners and patients.
Lipman AG
J Pain Palliat Care Pharmacother; 2004; 18(3):1-4. PubMed ID: 15364627
[No Abstract] [Full Text] [Related]
11. Ephedrine use is risky business.
Landry GL
Curr Sports Med Rep; 2003 Feb; 2(1):1-2. PubMed ID: 12831669
[No Abstract] [Full Text] [Related]
12. The need for regulation of dietary supplements--lessons from ephedra.
Fontanarosa PB; Rennie D; DeAngelis CD
JAMA; 2003 Mar; 289(12):1568-70. PubMed ID: 12672775
[No Abstract] [Full Text] [Related]
13. Ephedrine Alkaloids-Free Ephedra Herb Extract, EFE, Has No Adverse Effects Such as Excitation, Insomnia, and Arrhythmias.
Takemoto H; Takahashi J; Hyuga S; Odaguchi H; Uchiyama N; Maruyama T; Yamashita T; Hyuga M; Oshima N; Amakura Y; Hakamatsuka T; Goda Y; Hanawa T; Kobayashi Y
Biol Pharm Bull; 2018; 41(2):247-253. PubMed ID: 29386484
[TBL] [Abstract][Full Text] [Related]
14. Medicine. Ephedra--scientific evidence versus money/politics.
Wolfe SM
Science; 2003 Apr; 300(5618):437. PubMed ID: 12702860
[No Abstract] [Full Text] [Related]
15. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids.
Haller CA; Benowitz NL
N Engl J Med; 2000 Dec; 343(25):1833-8. PubMed ID: 11117974
[TBL] [Abstract][Full Text] [Related]
16. Health hazards and abuse with herbal dietary supplements.
Irby HE
J Miss State Med Assoc; 2002 Aug; 43(8):241-3. PubMed ID: 12349838
[No Abstract] [Full Text] [Related]
17. Ephedra and ephedrine for weight loss and athletic performance enhancement: clinical efficacy and side effects.
Shekelle P; Hardy ML; Morton SC; Maglione M; Suttorp M; Roth E; Jungvig L; Mojica WA; Gagné J; Rhodes S; McKinnon E
Evid Rep Technol Assess (Summ); 2003 Mar; (76):1-4. PubMed ID: 12647510
[No Abstract] [Full Text] [Related]
18. Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis.
Shekelle PG; Hardy ML; Morton SC; Maglione M; Mojica WA; Suttorp MJ; Rhodes SL; Jungvig L; Gagné J
JAMA; 2003 Mar; 289(12):1537-45. PubMed ID: 12672771
[TBL] [Abstract][Full Text] [Related]
19. Dietary supplements containing ephedra alkaloids.
Traub SJ; Hoyek W; Hoffman RS
N Engl J Med; 2001 Apr; 344(14):1096; author reply 1096-7. PubMed ID: 11291669
[No Abstract] [Full Text] [Related]
20. Ephedra ban: no shortage of reasons.
Rados C
FDA Consum; 2004; 38(2):6-7. PubMed ID: 15101356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
